Beyond the CRAB Symptoms: A study of presenting clinical manifestations of multiple myeloma

Clinical Lymphoma, Myeloma and Leukemia

Volumn 10, Issue 6, 2010, Pages 464-468

  Talamo, Giampaolo ^a   Farooq, Umar ^b   Zangari, Maurizio ^c   Liao, Jason ^a   Dolloff, Nathan G ^a   Loughran, Thomas P ^a   Epner, Elliot ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

^b Pinnacle Health System   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Anemia; Bone lesions; Cytopenia; Neuropathy; Renal insufficiency

Indexed keywords

CREATININE; URIC ACID;

ADULT; AGED; AMYLOIDOSIS; ANEMIA; ARTICLE; BACKACHE; BLEEDING; BLOOD CLOTTING DISORDER; BONE PAIN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYOGLOBULINEMIA; CYTOPENIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; GOUT; HUMAN; HYPERCALCEMIA; HYPERVISCOSITY SYNDROME; HYPONATREMIA; INFECTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NEUROPATHY; PATHOLOGIC FRACTURE; PLASMA CELL LEUKEMIA; RETROSPECTIVE STUDY; SURVIVAL RATE; URIC ACID BLOOD LEVEL; WEIGHT REDUCTION;

EID: 79952940092     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.3816/CLML.2010.n.080     Document Type: Article

References (17)

1. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group. Br J Haematol 2003; 121:749-57.
2. Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78:21-33. (Pubitemid 36033957)
3. Dispenzieri A, Kyle RA. Multiple myeloma: Clinical features and indications for therapy. Best Pract Res Clin Haematol 2005; 18:553-68. (Pubitemid 40984114)
4. Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: Emphasis on risk factors for progression. Br J Haematol 2007; 139:730-43. (Pubitemid 350115735)
5. Mehta J, Singhal S. Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost 2003; 29:467-71. (Pubitemid 37352646)
6. Benson WJ, Scarffe JH, Todd ID, et al. Spinal-cord compression in myeloma. BMJ 1979; 1:1541-4. (Pubitemid 9221158)
7. Dispenzieri A, Kyle RA. Neurological aspects of multiple myeloma and related disorders. Best Pract Res Clin Haematol 2005; 18:673-88. (Pubitemid 40984121)
8. Silverstein A, Doniger DE. Neurologic complications of myelomatosis. Arch Neurol 1963; 9:534-44.
9. Comenzo RL. Amyloidosis. Curr Treat Options Oncol 2006; 7:225-36.
10. Lesesve JF, Goasguen J. Cryoglobulin detection from a blood smear leading to the diagnosis of multiple myeloma. Eur J Haematol 2000; 65:77. (Pubitemid 30432025)
11. Paradisi F, Corti G, Cinelli R. Infections in multiple myeloma. Infect Dis Clin North Am 2001; 15:373-84 vii-viii. (Pubitemid 32606905)
12. Damaj G, Mohty M, Vey N, et al. Features of extramedullary and extraosseous multiple myeloma: A report of 19 patients from a single center. Eur J Haematol 2004; 73:402-6. (Pubitemid 39564362)
13. Blade J, Rosinol L. Complications of multiple myeloma. Hematol Oncol Clin North Am 2007; 21:1231-46 xi. (Pubitemid 350051348)
14. Ong F, Hermans J, Noordijk EM, et al. Presenting signs and symptoms in multiple myeloma: High percentages of stage III among patients without apparent myeloma-associated symptoms. Ann Hematol 1995; 70:149-52.
15. Riccardi A, Gobbi PG, Ucci G, et al. Changing clinical presentation of multiple myeloma. Eur J Cancer 1991; 27:1401-5.
16. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36:842-54.
17. Kyle RA. Multiple myeloma: Review of 869 cases. Mayo Clin Proc 1975; 50:29-40.